Paolo Visca

2.9k total citations
74 papers, 1.8k citations indexed

About

Paolo Visca is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Paolo Visca has authored 74 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 21 papers in Molecular Biology. Recurrent topics in Paolo Visca's work include Lung Cancer Treatments and Mutations (13 papers), Cancer, Lipids, and Metabolism (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Paolo Visca is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Cancer, Lipids, and Metabolism (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Paolo Visca collaborates with scholars based in Italy, United States and Malaysia. Paolo Visca's co-authors include Claudio Botti, Piero Alò, Ugo Di Tondo, Antonella Mangoni, Valeria Sebastiani, R. Perrone Donnorso, Giorgio Trombetta, Marcella Mottolese, Francesco Facciolo and Franca Del Nonno and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Paolo Visca

71 papers receiving 1.7k citations

Peers

Countries citing papers authored by Paolo Visca

Since Specialization

Citations

This map shows the geographic impact of Paolo Visca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Visca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Visca more than expected).

Fields of papers citing papers by Paolo Visca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Visca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Visca. The network helps show where Paolo Visca may publish in the future.

Co-authorship network of co-authors of Paolo Visca

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Visca. A scholar is included among the top collaborators of Paolo Visca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Visca. Paolo Visca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact and Reproducibility of In-House Targeted Next-Generation Sequencing Biomarker Testing in Non–Small-Cell Lung Cancer 2025 ·Journal of Molecular Diagnostics ·Ida Rapa, Francesca Bertola, Gaia Roversi, (unknown), Federica Panebianco, Cecília Durães, Enzo Gallo, Biagio Eugenio Leone, (unknown), Luisella Righi, Paolo Visca, Marco Volante, Simonetta Buglioni	0
2	AI drives the assessment of lung cancer microenvironment composition 2024 ·Journal of Pathology Informatics ·Enzo Gallo, (unknown), (unknown), (unknown), Simona Di Martino, (unknown), (unknown), (unknown), (unknown), Paolo Visca, Edoardo Pescarmona, Marialuisa Lavitrano, Paola Nisticò, Gennaro Ciliberto, Matteo Pallocca	0
3	The two Pseudomonas aeruginosa DksA stringent response proteins are largely interchangeable at the whole transcriptome level and in the control of virulence‐related traits 2021 ·Environmental Microbiology ·(unknown), Heike Bähre, Paolo Visca, Giordano Rampioni, Livia Leoni	3
4	Mesothelioma families without inheritance of a BAP1 predisposing mutation 2016 ·Cancer Genetics ·Valeria Ascoli, (unknown), Simona Vatrano, (unknown), Jessica Giorcelli, Elisa Romeo, (unknown), (unknown), Francesco Facciolo, Paolo Visca, Mauro Papotti, Luisella Righi	9
5	Usefulness of conventional transbronchial needle aspiration in the diagnosis, staging and molecular characterization of pulmonary neoplasias by thin-prep based cytology: experience of a single oncological institute 2016 ·Journal of Thoracic Disease ·(unknown), Ferdinando Marandino, Paolo Visca, (unknown), Enzo Gallo, Beatrice Casini, (unknown), (unknown), M Caterino, S. Carlini, Monica Rinaldi, Anna Ceribelli, (unknown), (unknown), Mirella Marino, Edoardo Pescarmona, (unknown)	4
6	Prognostic role of serum p53 antibodies in lung cancer 2015 ·BMC Cancer ·(unknown), Silvia Soddu, Andrea Prodosmo, Paolo Visca, (unknown), Gabriele Alessandrini, Francesco Facciolo, Lidia Strigari	33
7	An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation 2015 ·Cancer Genetics ·Mitchell Cheung, Yuwaraj Kadariya, Jianming Pei, Jacqueline Talarchek, Francesco Facciolo, Paolo Visca, Luisella Righi, (unknown), Joseph R. Testa, Valeria Ascoli	10
8	Biopsy of Different Oral Soft Tissues Lesions by KTP and Diode Laser: Histological Evaluation 2014 ·The Scientific World JOURNAL ·Umberto Romeo, (unknown), Gaspare Palaia, (unknown), Alessandro Del Vecchio, Paolo Visca, (unknown), Alberto De Biase	28
9	Ovarian metastasis from thyroid carcinoma: a case report and literature review 2014 ·Diagnostic Pathology ·Giacomo Corrado, Giulia Pomati, Andrea Russo, Paolo Visca, (unknown), Lodovico Patrizi, Enrico Vizza	10
10	Cyclin D1 is a major target of miR-206 in cell differentiation and transformation 2013 ·Cell Cycle ·Alessandra Alteri, Francesca De Vito, (unknown), (unknown), (unknown), Paolo Visca, Marcella Mottolese, Carlo Presutti, Milena Grossi	53
11	EGFR Molecular Profiling in Advanced NSCLC: A Prospective Phase II Study in Molecularly/Clinically Selected Patients Pretreated with Chemotherapy 2012 ·Journal of Thoracic Oncology ·Michèle Milella, Carmen Nuzzo, Emilio Bria, Isabella Sperduti, Paolo Visca, Fiamma Buttitta, Barbara Antoniani, Roberta Merola, Alain Gelibter, Federica Cuppone, Valerio D’Alicandro, Anna Ceribelli, Monica Rinaldi, Anna Maria Cianciulli, Lara Felicioni, Sara Malatesta, Antonio Marchetti, Marcella Mottolese, Francesco Cognetti	26
12	Melanoma molecular classes and prognosis in the postgenomic era 2012 ·The Lancet Oncology ·Elisa Tremante, (unknown), Elisa Lo Monaco, Pasquale Frascione, Franco Di Filippo, Irene Terrenato, Maria Benevolo, Marcella Mottolese, Edoardo Pescarmona, Paolo Visca, Pier Giorgio Natali, Patrizio Giacomini	26
13	Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas 2012 ·Journal of Experimental & Clinical Cancer Research ·Claudia Abbruzzese, Stefano Mattarocci, Laura Pizzuti, Anna Maria Mileo, Paolo Visca, Barbara Antoniani, Gabriele Alessandrini, Francesco Facciolo, Rosario Amato, Lucia D’Antona, Monica Rinaldi, Armando Felsani, Nicola Perrotti, Marco G. Paggi	62
14	Endometrial biopsy by means of the hysteroscopic resectoscope for the evaluation of tumor differentiation in endometrial cancer: A pilot study 2007 ·European Journal of Surgical Oncology ·Giuseppe Cutillo, Pietro Cignini, Paolo Visca, Enrico Vizza, (unknown)	13
15	Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer 2007 ·European Journal of Surgical Oncology ·Emilio Bria, Paolo Visca, Federica Novelli, Beatrice Casini, Maria Grazia Diodoro, (unknown), Claudio Botti, Isabella Sperduti, Francesco Facciolo, Michèle Milella, Fabiana Letizia Cecere, Francesco Cognetti, Marcella Mottolese	22
16	Fatty Acid Synthase Expression in Paget??s Disease of the Vulva 2005 ·International Journal of Gynecological Pathology ·Piero Alò, (unknown), Valeria Sebastiani, Francesca Ricci, Paolo Visca, Luciano Mariani, (unknown), Giuseppe Lombardi, Ugo Di Tondo	10
17	Liposomal Doxorubicin in the Perfusional Treatment of Advanced Soft Tissue Limb Sarcoma 2004 ·Journal of Chemotherapy ·Franco Di Filippo, Francesco Cavaliere, M Anzà, (unknown), Claudio Botti, Pasquale Perri, (unknown), (unknown), Simone Di Filippo, Paolo Visca	7
18	Role and prognostic significance of CD44s expression in colorectal cancer. 2003 ·PubMed ·Paolo Visca, Franca Del Nonno, Claudio Botti, Ferdinando Marandino, Valeria Sebastiani, Ugo Di Tondo, R. Perrone Donnorso, Giorgio Trombetta, (unknown), (unknown)	15
19	Cervical dysplasia, ploidy, and human papillomavirus status correlate with loss of Fhit expression. 2001 ·PubMed ·Andrea Vecchione, Nicola Zanesi, Giorgio Trombetta, Deborah French, Paolo Visca, (unknown), Claudio Botti, Carlo M. Croce, Rita Mancini	17
20	Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients 1996 ·Cancer ·Piero Alò, Paolo Visca, (unknown), Antonella Mangoni, Claudio Botti, Ugo Di Tondo	271

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact